Projects funded by the NCN

Functional dissection of three alpha(1)-adrenergic receptor subtypes in the effects of antidepressant drugs: exploitatio...

Call: OPUS 9 , Panel: NZ7

Principal investigator: prof. Irena Nalepa

Instytut Farmakologii PAN

The effect of typical and atypical neuroleptics on the expression of cytochrome P450 isoenzymes 1A2 (CYP1A2) and 3A4 (CY...

Call: PRELUDIUM 8 , Panel: NZ7

Principal investigator: Agnieszka Basińska-Ziobroń

Instytut Farmakologii PAN

Neural substrates of decision making under risk and uncertainty: role of phasic activity of dopamine neurons

Call: PRELUDIUM 8 , Panel: NZ4

Principal investigator: Przemysław Cieślak

Instytut Farmakologii PAN

Znaczenie interakcji układu endokanabinoidowego i endowaniloidowego w leczeniu bólu przewlekłego - potencjał terapeutycz...

Call: ETIUDA 3 , Panel: NZ7

Principal investigator: Natalia Małek

Instytut Farmakologii PAN

Wykorzystanie metod uczenia maszynowego w zadaniach komputerowo wspomaganego projektowania leków.

Call: ETIUDA 3 , Panel: NZ2

Principal investigator: Sabina Podlewska

Instytut Farmakologii PAN

Substructural Connectivity Fingerprint and Extreme Entropy Machines: A New Method of Compound Representation and Analysi...

Call: PRELUDIUM 9 , Panel: ST6

Principal investigator: Krzysztof Rataj

Instytut Farmakologii PAN

Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

Call: HARMONIA 7 , Panel: NZ7

Principal investigator: Sabina Podlewska

Instytut Farmakologii PAN

The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

Call: PRELUDIUM 4 , Panel: NZ4

Principal investigator: dr Ewelina Bator

Instytut Farmakologii PAN

The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

Call: OPUS 5 , Panel: NZ7

Principal investigator: prof. Agnieszka Basta-Kaim

Instytut Farmakologii PAN

Effect of caffeine on neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse brain.

Call: PRELUDIUM 6 , Panel: NZ7

Principal investigator: Anna Górska

Instytut Farmakologii PAN

The influence of 5-HT7 and NMDA receptor ligands with possible antidepressive properties on the activity of rat dorsal r...

Call: OPUS 6 , Panel: NZ4

Principal investigator: prof. Grzegorz Hess

Instytut Farmakologii PAN

The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

Call: OPUS 6 , Panel: NZ7

Principal investigator: dr hab. Jacek Wójcikowski

Instytut Farmakologii PAN

Involvement of cyclooxygenase 2 in antidepressant-like effects of metabotropic glutamatergic receptors group I.

Call: SONATA 7 , Panel: NZ7

Principal investigator: dr Katarzyna Stachowicz

Instytut Farmakologii PAN

The impact of maternal diabetes on inflammasome NLRP3 activation in the offspring brain

Call: PRELUDIUM 7 , Panel: NZ7

Principal investigator: dr Katarzyna Głombik

Instytut Farmakologii PAN

The role of the factors involved in the brain glucose metabolism in the model of obesity and depression comorbidity

Call: OPUS 7 , Panel: NZ7

Principal investigator: prof. Bogusława Budziszewska

Instytut Farmakologii PAN

Define the role and modulation of immune diabetes changed factors - their importance to the action of analgesics.

Call: PRELUDIUM 3 , Panel: NZ4

Principal investigator: Magdalena Żychowska

Instytut Farmakologii PAN

Probing the selectivity of zinc allosteric modulation in various serotonin receptor subtypes

Call: PRELUDIUM 3 , Panel: NZ7

Principal investigator: Grzegorz Satała

Instytut Farmakologii PAN

The influence of the serotonergic system on the regulation of liver CYP activity in hepatocellular carcinoma

Call: SONATA 4 , Panel: NZ4

Principal investigator: dr Marta Kot

Instytut Farmakologii PAN

The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m...

Call: OPUS 4 , Panel: NZ7

Principal investigator: dr Agnieszka Wąsik

Instytut Farmakologii PAN